Medipore Tape Study

NYU Langone Health

Status: Completed

Conditions: Scarring

Treatments: Other: Medipore Tape; Other: Standard Post Operative Skin Care

Study type: Interventional

Funder types: Other

Identifiers

NCT02676115

15-00048

Details and patient eligibility

About

This is a prospective, single-blinded, two-arm, randomized, parallel, pragmatic, effectiveness trial that will enroll patients undergoing arthroscopic anterior cruciate ligament reconstruction in order to evaluate the efficacy of using Medipore tape to improve cosmetic wound healing and scaring.

Enrollment: 60 patients

Sex: All

Ages: 15 to 95 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• All patients undergoing arthroscopic ACL reconstruction with bone-patella-tendon-bone autograft at the Ambulatory Surgical Center and Hospital for Joint Diseases will be eligible for enrollment.
• Patient is indicated for ACL reconstructive surgery with bone-patella-tendon-bone autograft

Exclusion criteria

• Subjects/Parents who are mentally impaired and are unable to give consent
• Patients with prior vertical anterior knee incisions
• Patients with known skin reactions to adhesive
• Patients with high risk for abnormal scar formation and keloids

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Control Group

Active Comparator group

Description:

Standard Post Operative Skin Care

Treatment:

Other: Standard Post Operative Skin Care

Treatment Group

Experimental group

Description:

Medipore Tape will be applied to ACL reconstruction Incision

Treatment:

Other: Medipore Tape